Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity.

Kerick M, Isau M, Timmermann B, Sültmann H, Herwig R, Krobitsch S, Schaefer G, Verdorfer I, Bartsch G, Klocker H, Lehrach H, Schweiger MR.

BMC Med Genomics. 2011 Sep 29;4:68. doi: 10.1186/1755-8794-4-68.

2.

Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization.

Do H, Dobrovic A.

Clin Chem. 2015 Jan;61(1):64-71. doi: 10.1373/clinchem.2014.223040. Epub 2014 Nov 24. Review.

3.

Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.

Fairley JA, Gilmour K, Walsh K.

Curr Drug Targets. 2012 Nov;13(12):1475-87. Review.

PMID:
22974391
4.

Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.

Dunn TA, Fedor HL, De Marzo AM, Luo J.

Asian J Androl. 2012 May;14(3):385-92. doi: 10.1038/aja.2011.147. Epub 2012 Feb 6. Review.

5.

Pathology in prostate research: optimizing tissue quality.

Berney DM, Montironi R, Egevad L.

Acta Oncol. 2011 Jun;50 Suppl 1:53-5. doi: 10.3109/0284186X.2010.525224. Review.

PMID:
21604941
6.

Massively parallel sequencing: the new frontier of hematologic genomics.

Johnsen JM, Nickerson DA, Reiner AP.

Blood. 2013 Nov 7;122(19):3268-75. doi: 10.1182/blood-2013-07-460287. Epub 2013 Sep 10. Review.

7.

Incorporating genomics into breast cancer clinical trials and care.

Tabchy A, Ma CX, Bose R, Ellis MJ.

Clin Cancer Res. 2013 Dec 1;19(23):6371-9. doi: 10.1158/1078-0432.CCR-13-0837. Review.

8.

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T.

Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Review.

9.

[Molecular diagnostics in pathology].

Stenzinger A, Penzel R, Endris V, Weichert W.

Dtsch Med Wochenschr. 2013 May;138(20):1061-8. doi: 10.1055/s-0033-1343106. Epub 2013 May 13. Review. German.

PMID:
23670263
10.

The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies.

Zhang P, Lehmann BD, Shyr Y, Guo Y.

Int J Genomics. 2017;2017:1926304. doi: 10.1155/2017/1926304. Epub 2017 Jan 26. Review.

11.

The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.

Wyatt AW, Mo F, Wang Y, Collins CC.

Asian J Androl. 2013 May;15(3):301-8. doi: 10.1038/aja.2013.13. Epub 2013 Mar 18. Review.

12.

The complexity of prostate cancer: genomic alterations and heterogeneity.

Boyd LK, Mao X, Lu YJ.

Nat Rev Urol. 2012 Nov;9(11):652-64. doi: 10.1038/nrurol.2012.185. Review.

PMID:
23132303
13.

Cancer heterogeneity: implications for targeted therapeutics.

Fisher R, Pusztai L, Swanton C.

Br J Cancer. 2013 Feb 19;108(3):479-85. doi: 10.1038/bjc.2012.581. Epub 2013 Jan 8. Review.

14.

Genetic aberrations as the targets of oncology research: Involvement of paraffin-embedded tissues.

Dobashi Y, Goto A, Endo T, Ooi A.

Histol Histopathol. 2014 Feb;29(2):191-205. doi: 10.14670/HH-29.191. Epub 2013 Nov 5. Review.

PMID:
24190012
15.

Reverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Use.

Boellner S, Becker KF.

Microarrays (Basel). 2015 Mar 24;4(2):98-114. doi: 10.3390/microarrays4020098. Review.

16.

Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research.

Ye B, Gao Q, Zeng Z, Stary CM, Jian Z, Xiong X, Gu L.

Anal Cell Pathol (Amst). 2016;2016:9369240. doi: 10.1155/2016/9369240. Epub 2016 May 25. Review.

17.

Computational Methods for Characterizing Cancer Mutational Heterogeneity.

Vandin F.

Front Genet. 2017 Jun 14;8:83. doi: 10.3389/fgene.2017.00083. eCollection 2017. Review.

18.

Detection of single cell heterogeneity in cancer.

Qian M, Wang DC, Chen H, Cheng Y.

Semin Cell Dev Biol. 2017 Apr;64:143-149. doi: 10.1016/j.semcdb.2016.09.003. Epub 2016 Sep 13. Review.

PMID:
27619166

Supplemental Content

Support Center